Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Bloom Health Partners flags strong revenue growth for fiscal 2022 

The Vancouver-based firm said it anticipates revenue of C$25 million to C$28 million for the year to September 30, 2022, from continued business with new and existing clients and markets

Bloom Health Partners Inc (CSE:BLMH, OTCQB:BLMHF), the occupational health provider, has told investors it expects to report strong growth in revenue and positive underlying earnings (EBITDA) from its operations in fiscal 2022 as they continue to gain momentum.

In a corporate update, the Vancouver-based firm said it anticipates revenue of C$25 million to C$28 million for the year to September 30, 2022, from continued business with new and existing clients and markets.

Bloom Health also detailed its recent expansion as it positions its operations for growth, including the opening in November 2021 of a new facility in Dallas, expanded lab capacity in Atlanta to meet demand from clients in the region, and a new laboratory in New Jersey to serve a growing customer base in New York, New Jersey and the surrounding region.

READ: Bloom Health Partners sees strong revenue of $9.8M in 2021 fiscal year driven by its operational health platform

The company noted that it has a strong client list to help support growth as it builds its Operational Health and Health-Tech business in 2022.

In November 2021, it announced a state contract for schools across the state of Alabama. That was followed in January 2022 with a contract for testing at schools across the state of Texas. Bloom said it also continues to test for major film and television productions in the New York area, Atlanta and Dallas.

Additionally, it is providing a cloud software platform to all current clients to manage and track health services and is bringing new types of health services to market as it expands its client base and services.

"Our team has done the groundwork for our next stage of growth," CEO Andrew Morton said in a statement.

"Our contract announcements with Alabama and Texas add to our ongoing business with film/TV productions, such as Ozark and Fortune 500 clients. All of which are a foundation for our team to deliver comprehensive Operational Health Services in new areas, such as employee health management, wellness and mental health - all backed by a secure, cloud data platform.

“With a focus on keeping businesses and organizations running, we're executing on our mission of 'Unstoppable is Possible' for our clients,” Morton concluded.

Contact the author at stephen.gunnion@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK